These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15839442)

  • 1. The relationship between anticardiolipin antibodies and vascular access occlusion in patients on hemodialysis.
    Gültekin F; Alagözlü H; Candan F; Nadir I; Bakici MZ; Sezer H
    ASAIO J; 2005; 51(2):162-4. PubMed ID: 15839442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM-anticardiolipin antibody and vascular access thrombosis in chronic hemodialysis patients.
    Chuang FR; Chen TC; Yang CC; Cheng YF; Hsu KT; Lee CH; Lin CL; Wang IK; Chang HW; Wang PH
    Ren Fail; 2005; 27(1):25-30. PubMed ID: 15717631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
    Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
    Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients.
    Roozbeh J; Serati AR; Malekhoseini SA
    Arch Iran Med; 2006 Jan; 9(1):26-32. PubMed ID: 16649374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis.
    Prakash R; Miller CC; Suki WN
    Am J Kidney Dis; 1995 Aug; 26(2):347-52. PubMed ID: 7645540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticardiolipin antibodies in hemodialysis patients and in renal transplant recipients: prevalence and significance].
    Ferlazzo B; Barrile A; Bonanno D; Quattrocchi P; Santoro D; Savica V; Bellinghieri G
    Recenti Prog Med; 1998 Sep; 89(9):434-7. PubMed ID: 9796372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure.
    Ozmen S; Danis R; Akin D; Batun S
    Clin Nephrol; 2009 Sep; 72(3):193-8. PubMed ID: 19761724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis.
    Shafi ST; Gupta M
    J Vasc Access; 2007; 8(2):103-8. PubMed ID: 17534796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: cause or effect?
    Haviv YS
    Nephron; 2000 Dec; 86(4):447-54. PubMed ID: 11124593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticardiolipin antibodies in hemodialysis patients.
    Ozdemir N; Güz G; Sezer S; Haberal A; Ayaz H; Haberal M
    Transplant Proc; 1999 Dec; 31(8):3388-9. PubMed ID: 10616518
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombophilia Associated with Early Post-angioplasty Thrombosis of Dialysis Vascular Access.
    Chen TY; Lin L; Hsieh MY; Chen CH; Chen MK; Wu CC
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1683-1690. PubMed ID: 30066093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke.
    Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
    Rom J Intern Med; 2003; 41(2):189-204. PubMed ID: 15526503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus.
    Escalante A; Brey RL; Mitchell BD; Dreiner U
    Am J Med; 1995 Jun; 98(6):559-65. PubMed ID: 7778571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients.
    Molino D; De Santo NG; Marotta R; Anastasio P; Mosavat M; De Lucia D
    Semin Nephrol; 2004 Sep; 24(5):495-501. PubMed ID: 15490419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events.
    Locht H; Wiik A
    Clin Rheumatol; 2006 Mar; 25(2):246-50. PubMed ID: 16177835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies.
    Sairam S; Baethge BA; McNearney T
    Clin Rheumatol; 2003 Feb; 22(1):24-9. PubMed ID: 12605313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
    Visvanathan S; Wagner C; Smolen J; St Clair EW; Hegedus R; Baker D; Keenan G
    Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the anticardiolipin antibodies a risk factor for coronary artery disease in chronic renal failure patients?
    Ucar E; Kuvandik G; Sert M; Kuvandik C; Temizkan A; Borazan A
    Ren Fail; 2008; 30(8):791-5. PubMed ID: 18791953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience.
    Anapalli SR; N HD; Sarma P; Srikanth L; V SK
    Ren Fail; 2022 Dec; 44(1):34-42. PubMed ID: 35094650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.